@Just4NowOn@theproof The folks with PCSK9 LoF run v. low LDL-C with zero problems, but 88% ⬇️ in ASCVD. In genetic ABL zero probs. from complete absence of ApoB lipoproteins per se. Inclisiran’s GaLNAC/ASGPR specificity = normal absorption of fat soluble vits. My vits + steroid hormones all normal.
@Just4NowOn@theproof Rosuvastatin 40 mg/d (prob.⬇️ to 20mg [flat DR curve]. Zero SE’s, like extra anti-inflamm. effect, ?keep 40mg!); Ezetimibe 10 mg/d + Inclisiran (prev. used Repatha-similar results - £++ in UK). Obv. Inclisiran outcome data awaited (soon). IMO LDL-C doesn’t care how you ⬇️ it!
@theproof Repatha is good stuff. Nice auto-injector too - for anyone concerned about needles you don’t even see it. And the pressure of the yellow guard against your skin seems to make the injection feel barely noticeable.
@KayBwt@Drlipid@nytimes Yeah, sure and I guess you think all the Mendelian randomisation lipid data is wrong too. How do you explain the folks with the PCSK9 LoF genetic variant (1-3% of the population) who have been studied extensively and shown to have 88% less ASCVD than the rest of the population?
@0ivankaTrump1 The Crooked News Network aka CNN is worse than any President in the history of the world and it was never elected by anyone. It’s just a bunch of woke, coastal elite, lefties who like the sound of their own voices. I wouldn’t trust them to walk my dog!
@MohammedAlo How about a statin + ezetimibe + Inclisiran? In the UK the NHS has negotiated a volume based population level pricing deal that brings the cost of Inclisiran down to £150 per year. With that approach we can drop LDL-C to levels seen in a newborn — plaque progression is halted.
@theproof If you drop LDL-C / ApoB to the levels where studies (e.g. GLAGOV & PACMAN-AMI) show plaque progression halts and even regresses then your entire arterial tree is protected from plaque.
@theproof By definition the population average is what gives us the modern “epidemic” of cardiovascular disease. Evolution designed us for a ~ 40 year reproductive lifespan and then in evolutionary terms we are surplus to requirements. We need to aim for the physiological target.
@TrumpRealDaily Are you joking? The guy who put computing back 20 years with his glitchy OS and his possible associations with certain islands and all the rest - give us a break! Leave him to the stack of Microsoft error reports that must stretch beyond the Moon all the way to Mars by now!